Search results :

Lantus

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A10AE04

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Hypoglycaemia Hypoglycaemia 25.5% - 33% x x x x x x x
Hypoglycemic reaction 2.56% - 3.42% x x
Hypoglycaemic episode x
Oedema peripheral Oedema peripheral 1.79% - 22.7% x x x x
Hypertension Hypertension 18.9% - 19.6% x x x
Influenza Influenza 18.7% - 19.5% x x x x
Upper respiratory tract infection Upper respiratory tract infection 11.4% - 33.6% x x x x x
Sinusitis Sinusitis 3.23% - 18.5% x x x x x
Cataract Cataract 15.9% - 18.1% x x x
Arthralgia Arthralgia 14.2% - 16.1% x x x
Musculoskeletal discomfort Arthralgia 14.2% - 16.1% x x x
Myalgia x
Bronchitis Bronchitis 14.1% - 15.2% x x x x
Pain in extremity Pain in extremity 13% - 13.1% x x x x
Back pain Back pain 2.69% - 12.8% x x x x
Diarrhoea Diarrhoea 10.3% - 10.7% x x x x
Infection Infection 8.64% - 17.7% x x x x x
Depression Depression 9.7% - 10.5% x x x
Urinary tract infection Urinary tract infection 1.95% - 10.7% x x x x
Cough Cough 7.4% - 12.1% x x x
Cough increased x
Pharyngitis Pharyngitis 7.5% - 8.6% x x x x
Retinal vascular disorder Retinal vascular disorder 3.89% - 7.4% x x x x
Neoplasm malignant Neoplasm malignant 3.02% - 8.53% x
Injury Accidental injury 4.8% - 6.4% x x x x x
Headache Headache 4.15% - 10.3% x x x x x
Rhinitis Rhinitis 2.9% - 5.2% x x x x x
Injection site haemorrhage Injection site haemorrhage 4.23% - 4.54% x x
Gastroenteritis Gastroenteritis 3.23% - 3.59% x x
Neuropathy peripheral Neuropathy 2.52% x
Neuropathy peripheral x x x
Injection site pain Injection site pain 0.729% - 2.61% x x x x x x
Abdominal pain Abdominal pain x
Gastrointestinal pain Abdominal pain x
Anaphylactic shock Anaphylactic shock x x x
Angioedema Angioedema x x x x x
Asthma Asthma x
Diabetic retinopathy Background diabetic retinopathy x x x
Benign neoplasm of skin Benign neoplasm of skin x
Bone disorder Bone disorder x
Bronchospasm Bronchospasm x x x x x
Coma Coma x
Connective tissue disorder Connective tissue disorder x
Fungal skin infection Fungal skin infection x
Dysgeusia Dysgeusia x
Eczema Eczema x
Oedema Oedema x x x x x
Dermatitis Rash x x x
Rash Rash x x x
Multiple fractures Fracture x
Fracture Fracture x
Glycosuria Glycosuria x x x
Cardiac failure Cardiac failure x
Herpes zoster Herpes zoster x
Hypernatraemia Hypernatraemia x x x x x
Hypersensitivity Hypersensitivity x x x x x x x
Hypotension Hypotension x x x x x
Immune system disorder Immune system disorder x
Inflammation Inflammation x x x x x
Ketosis Ketosis x
Lipodystrophy acquired Lipodystrophy x x x x x x x
Myocardial infarction Myocardial infarction x
Acute coronary syndrome Myocardial infarction x
Nervous system disorder Nervous system disorder x
Pain Pain x x x x x
Pruritus Pruritus x x x x x x x
Refraction disorder Refraction disorder x x x
Retinal disorder Retinal disorder x x x x x x x
Shock Shock x x x x x
Cerebrovascular accident Cerebrovascular accident x
Swelling Swelling x x
Loss of consciousness Loss of consciousness x
Urticaria Urticaria x x x x x x
Weight increased Weight increased x x x
Injection site reaction Injection site reaction x x x x x x x
Injection site mass Injection site mass x
Malnutrition Malnutrition x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Myalgia Myalgia x
Oropharyngeal discomfort Throat sore x
Oropharyngeal pain Throat sore x
Glucose tolerance impaired Glucose tolerance impaired x
Erythema Redness x x x x x
Neuroglycopenia Neuroglycopenia x
Amaurosis Amaurosis x x
Application site pain Application site pain x x x x
Instillation site pain Application site pain x x x x
Blood glucose abnormal Blood glucose abnormal x
Diabetes mellitus Worsening of diabetes x x x x x x
Lipohypertrophy Lipohypertrophy x x x x
Impaired fasting glucose Impaired fasting glucose x
Lipoatrophy Lipoatrophy x x x x
Blindness Blindness, both eyes x
Visual impairment Visual impairment x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

INSULIN GLARGINE RECOMBINANT / LANTUS

Side effects:9
Source:FDA

INSULIN GLARGINE / LANTUS -(VIAL)

Side effects:41
Source:Health Canada

insulin glargine / insulin glargine

Side effects:32
Source:EMA

Lantus

Side effects:35
Source:medicines.org.au

INSULIN GLARGINE

Side effects:47
Source:FDA Structured Product Label

INSULIN GLARGINE

Side effects:49
Source:FDA Structured Product Label

insulin glargine

Side effects:52
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label